Citation: | CHEN Wenhua, ZOU Limin, ZHANG Fei, ZHANG Liandi, LIAO Mingyi, DING Li. Identification of the related substances in bendamustine hydrochloride[J]. Journal of China Pharmaceutical University, 2015, 46(3): 333-338. DOI: 10.11665/j.issn.1000-5048.20150312 |
[1] |
Cuneo A,Marchetti M,Barosi G,et al.Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia.Recommendations from SIE,SIES,GITMO Group[J].Leukemia Res,2014,38(11):1269-1277.
|
[2] |
Höffken K,Merkle KH,Schönfelder M,et al.Bendamustine as salvage treatment in patients with advanced progressive breast cancer:a phase II study[J].J Cancer Res Clin,1998,124(11):627-632.
|
[3] |
Elefante A, Czuczman MS. Bendamustine for the treatment of indolent non-Hodgkin′s lymphoma and chronic lymphocytic leukemia[J].Am J Health Syst Pharm,2010,67(9):713-723.
|
[4] |
Pönisch W,Dietger N.Bendamustine in the treatment of multiple myeloma:results and future perspectives[J].Semin Oncol,2002,29(4):23-26.
|
[5] |
Liu ZR,Ye XL,Fan GR,et al.Electrospray ionization tandem mass spectrometry analysis of bendamustine hydrochloride[J].Pharm Care Res(药学服务与研究),2012,12(6):414-417.
|
[6] |
Liu ZR,Ye XL,Fan GR.Degradation compounds and their structural confirmation of bendamustine hydrochloride in process of clinical administration[J].Chin J New Drugs Clin Rem(中国新药与临床杂志),2013,32(3):211-216.
|
[7] |
Mathrusri AM,Venkatesh B,Anusha S,et al.Stability-indicating liquid chromatographic method for the determination of bendamustine hydrochloride in parenterals[J].Res J Chem Sci,2012,2(9):72-78.
|
[8] |
Tang H,Wu XM,Peng S.Determination of bendamustine hydrochloride and related substance by HPLC[J].Pharm Clin Res(药学与临床研究),2009,17(4):303-305.
|
[9] |
Kasa S,Reddy MRS.Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities[J].J Chromatogr Sci,2014,52(7):573-583.
|
[1] | WU Xufeng, CHAI Shiying, LIU Jianhong, WANG Zhihui, YIN Ruifeng, CAO Ruiwei, SUN Xinqiang. Improvement of synthetic route of brivudine[J]. Journal of China Pharmaceutical University, 2022, 53(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20220106 |
[2] | WANG Dong, ZHONG Jian, WANG Ling, ZHOU Zhihui, JIANG Haiting, LUO Peng, WANG Xizhi, WANG Chongyi. Improved synthetic process of apremilast[J]. Journal of China Pharmaceutical University, 2021, 52(5): 536-540. DOI: 10.11665/j.issn.1000-5048.20210504 |
[3] | HAN Chengqun, ZOU Qiaogen, SUN Qian, XIA Yunyan. Improvement of synthesis process of mirabegron[J]. Journal of China Pharmaceutical University, 2020, 51(4): 449-453. DOI: 10.11665/j.issn.1000-5048.20200409 |
[4] | ZHANG Qiuyue, YOU Qidong, YANG Jinpeng. Process improvement on the synthesis of atomoxetine[J]. Journal of China Pharmaceutical University, 2019, 50(4): 405-409. DOI: 10.11665/j.issn.1000-5048.20190404 |
[5] | LIU Li, WANG Chen, LIU Lixin, JI Tingting. Improved synthesis of analgesic pentazocine[J]. Journal of China Pharmaceutical University, 2018, 49(5): 568-571. DOI: 10.11665/j.issn.1000-5048.20180508 |
[6] | CHEN Suting, CHEN Song, GAO Xiangdong. Construction, expression, purification and neuroprotective activity of TAT-FGF21 fusion protein[J]. Journal of China Pharmaceutical University, 2018, 49(4): 496-501. DOI: 10.11665/j.issn.1000-5048.20180417 |
[7] | WEI Qingjie, QIAO Junhua, CHEN Jianjun, GAO Zhigang, LI Yaqing. An improvement for synthesis of ceftriaxone sodium[J]. Journal of China Pharmaceutical University, 2016, 47(2): 163-165. DOI: 10.11665/j.issn.1000-5048.20160206 |
[8] | WU Jiaquan, ZHOU Ping, LIU Yang, JIE Chuanming, CAO Huanyan, PENG Tao, LI Xiaohong, ZHANG Haijun. An improved preparing process for rivastigmine[J]. Journal of China Pharmaceutical University, 2015, 46(4): 421-425. DOI: 10.11665/j.issn.1000-5048.20150406 |
[9] | Effects of Hypericin on Behavior and Proliferation of Ependymocytes and Subependymocytes of Rat with Olfactory Bulb Impairment[J]. Journal of China Pharmaceutical University, 2004, (2): 48-52. |
[10] | Effects of Hypericin on Behavior and Expression of 5-HT and NE in Brain of Depression Rat with Chronic Stress[J]. Journal of China Pharmaceutical University, 2003, (1): 72-75. |